Direct-acting antiviral therapy has reduced the prevalence of hepatitis C viremia over time among adults with HIV infection in the United States. The prevalence of hepatitis C virus (HCV) has ...
How will the Trump administration's cuts to HIV research impact the progress that's been made towards ending the epidemic in the U.S.? PRESIDENT DONALD TRUMP: My budget will ask Democrats and ...
Gilead Sciences has announced a collaboration with the US State Department and the President’s Emergency Plan for AIDS Relief (PEPFAR) to distribute its injectable HIV-1 capsid inhibitor, lenacapavir, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback